检索

标题
作者
The clinical and hemostasiological features of chronic hepatitides of different genesis
Bilalova A., Makashova V., Astrina O., Aleshina N., Florianu A.
The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia
Pimenov N., Vdovin A., Komarova S., Mamonova N., Chulanov V., Pokrovskiĭ V.
A variety of extrahepatic manifestations of chronic viral hepatitis B and C: basic treatment principles
Baĭkova T., Lopatkina T.
Role of transforming growth factor-beta in the development of some liver diseases
Raĭkhel'son K., Karev V., Marchenko N., Semenov N., Pal'gova L., Baranovskiĭ A.
Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C
Nozhkin M., Lioznov D., Antonova T., Gorchakova O., Goldstein E., Popova M., Shneyder T.
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage
Buyeverov A., Bogomolov P., Mayev I., Matsievich M., Uvarova O.
Insulin resistance and chronic hepatitis C
Tkachenko L., Maleev V.
An IL-6 level in the serum and urine in estimation of cryoglobulinemic vasculitis activity in patients with chronic hepatitis C associated with renal damage
Korotchaeva Y., Kozlovskaya L., Gordovskaya N., Speranskiy A., Korotchaeva Y., Kozlovskaya L., Gordovskaya N., Speransky A.
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy
Dudina K., Belyy P., Maev I., Klimova E., Shutko S., Znoyko O., Yuschuk N.
Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C
Grushko I., Romanova E., Tverdokhlebova T., Gapon M., Vodyanitskaya S.
Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
Ibragimov E., Abdurakhmanov D., Rozina T., Nikulkina E., Tanaschuk E., Odintsov A., Panevkina S., Moiseev S.
A histological response to antiviral therapy for chronic hepatitis C in patients who failed to achieve a sustained virological response
Riumin A., Korochkina O.
Comparative characteristics of porphirine metabolism in chronic viral diseases of the liver
Krivosheev A., Kondratova M., Krivosheev B., Morozov D., Danilenko D., Krivosheev A., Kondratova M., Krivosheev B., Morozov D., Danilenko D.
Comparative efficacy of combined treatment with intron A and pegintron in combination with ribavirin in patients with chronic hepatitis С
Gromova N., Bogomolov B.
Sjogren's syndrome in chronic hepatitis C: clinical features and diagnosis
Chernetsova O., Lopatkina T., Popova I., Vorobyev A., Shipulina О., Safonova T., Ponomarev A.
Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment
Milovanova S., Kozlovskaya(Lysenko) L., Milovanova L., Gordovskaya N., Ignatova T., Taranova M., Androsova T.
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
Maev I., Kuznetsova E., Andreev D., Dicheva D.
Prediction of features of the course of chronic hepatitis C using Bayesian networks
Samokhodskaya L., Starostina E., Sulimov A., Krasnova T., Rosina T., Avdeev V., Savkin I., Sulimov V., Mukhin N., Tkachuk V., Sadovnichii V.
Predictors of the efficiency of short-term interferon-containing therapy using direct-acting antiviral drugs in patients with chronic hepatitis C virus genotype 1
Kokina K., Bueverov A., Bogomolov P., Matsievich M.
The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants
Yushchuk N., Znoyko O., Dudina K., Kozina A., Kalininа O.
Topical problems of antiviral therapy for chronic hepatitis C
Bakulin I.
Catalase gene rs1001179 polymorphism and oxidative stress in patients with chronic hepatitis C and ulcerative colitis
Bulatova I., Tret'iakova I., Shchekotov V., Shchekotova A., Ulitina P., Krivtsov A., Nenasheva O.
Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance
Tkachenko L., Maleev V.
Significance of allelic variants of interleukin-28B gene in chronic hepatitis C
Tikhonova N., Burnevich É., Krasnova T.
Hepatitis C virus Genotype 3: that "simple", yet that "complex"
Batskikh S., Morozov S., Chulanov V., Pokrovskiĭ V.
Regulators of fibrinolysis in chronic viral pathology of the liver
Yagoda A., Kopoy P., Yagoda A., Koroi P.
To the problem of extended serological testing for viral hepatitis B in rheumatoid arthritis patients
Gridneva G., Belov B., Verizhnikova Z., Aronova E., Samarkina E., Panevin T., Lisitsyna T., Lukina G.
Evaluation of lipid peroxidation processes in patients with chronic parenteral viral hepatitis and HIV co-infection depending on degree of inflammatory process activity in the liver
Kolesnikova L., Darenskaya M., Kolesnikov S., Grebenkina L., Rashidova M., Timofeeva E., Leshenko O., Nikitina O.
Myocardial injury associated with chronic hepatitis C: Clinical types and pathogenetic components
Strizhakov L., Karpov S., Fomin V., Lopatkina T., Tanashchuk E., Taranova M.
Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C
Burnevich É.
Triple therapy for chronic hepatitis C: Practical Aspects
Bakulin I., Kiseleva A.
The clinical efficacy of a succinate-containing infusion drug during pharmacotherapy for hepatic lesions of varying genesis: results of meta-analysis
Mazina N., Mazin P., Sukhanov D.
EFFICACY OF COMBINED IMMUNOCORRECTION IN THE TREATMENT OF CHRONIC VIRAL HEPATITIS C
Frolov V., Sotskaya Y.
Clinical significance of intravital morphological investigation of the liver
Khomeriki S., Yakimchuk G., Golovanova E., Homeriki S., Yakimchuk G., Golovanova E.
Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)
Sologub T., Romantsov M., Shul'dyakov A., Lin'kova Y., Radchenko V., Kovalenko A., Sologub T., Romantsov M., Shuldyakov A., Linkova Y., Radchenko V., Kovalenko A.
The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C
Tkachenko L., Maleev V.
Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2
Znoyko O., Dudina K., Kozina A., Kalininа O., Yushchuk N.
Chronic hepatitis C in Russia: current challenges and prospects
Chulanov V., Pimenov N., Mamonova N., Sagalova O., Shestakova I., Pokrovsky V.
Entecavir in the treatment of chronic hepatitis B: multicenter randomized trials and real clinical practice
Abdurakhmanov D., Otrashevskaia A.
Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
Antonova T., Romanova M., Lymar' I.
Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
Nikitin I., Gogova L., Baĭkova I., Kisliakov V., Volynkina V.
The course and treatment of chronic hepatitis B in HIV-infected patients
Maksimov S., Tsarenko S., Kravchenko A., Yushchuk N., Maksimov S., Tsarenko S., Kravchenko A., Yushchuk N.
Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review
Gridneva G., Belov B., Aronova E.
Activity an enzyme 5`-nucleotidase in patients with chronic hepatitis C
Galeeva N., Valeeva I.
Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B
Kostyushev D., Zueva A., Brezgin S., Lipatnikov A., Simirskii V., Glebe D., Volchkova E., Shipulin G., Chulanov V.
Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice
Znoyko O., Klimova E., Maevskaya M., Shuldyakov А., Linkova Y., Morozova M.
Endothelial dysfunction gene polymorphisms and the rate of liver fibrosis in chronic hepatitis C
Taratina O., Krasnova T., Samokhodskaia L., Lopatkina T., Tkachuk V., Mukhin N.
Metabolic correctors based on siccine acid as pathogenic therapy in chronic virus hepatitis
Stel'makh V., Radchenko V., Kozlov V., Stelmakh V., Radchenko V., Kozlov V.
Metabolic syndrome and insulin resistance in patients with chronic hepatitis C
Bayzhanova Z., Ignatova T., Nekrasova T., Baizhanova Z., Ignatova T., Nekrasova T.
HBeAg-negative chronic hepatitis
Ibragimova M., Krel P., Abdurakhmanov D.
1 - 50 的 67 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语